TP53RK and cancer: Suppressing PRPK activation with its inhibitor, rocuronium bromide, effectively attenuated solar simulated light (SSL)–induced photocarcinogenesis in mouse models, suggesting its potential as a therapeutic target in cancer prevention (Roh et al, 2018).